Mannermaa A - Search Results

1

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.

Sung H, Garcia-Closas M, Chang-Claude J, Blows FM, Ali HR, Figueroa J, Nevanlinna H, Fagerholm R, Heikkilä P, Blomqvist C, Giles GG, Milne RL, Southey MC, McLean C, Mannermaa A, Kosma VM, Kataja V, Sironen R, Couch FJ, Olson JE, Hallberg E, Olswold C, Cox A, Cross SS, Kraft P, Tamimi RM, Eliassen AH, Schmidt MK, Bolla MK, Wang Q, Easton D, Howat WJ, Coulson P, Pharoah PD, Sherman ME, Yang XR. Sung H, et al. Among authors: mannermaa a. Br J Cancer. 2016 Feb 2;114(3):298-304. doi: 10.1038/bjc.2015.437. Epub 2015 Dec 17. Br J Cancer. 2016. PMID: 26679376 Free PMC article.

2

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.

Karjalainen JM, Kellokoski JK, Mannermaa AJ, Kujala HE, Moisio KI, Mitchell PJ, Eskelinen MJ, Alhava EM, Kosma VM. Karjalainen JM, et al. Among authors: mannermaa aj. Br J Cancer. 2000 Jun;82(12):2015-21. doi: 10.1054/bjoc.2000.1145. Br J Cancer. 2000. PMID: 10864211 Free PMC article.

3

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.

Sarantaus L, Huusko P, Eerola H, Launonen V, Vehmanen P, Rapakko K, Gillanders E, Syrjäkoski K, Kainu T, Vahteristo P, Krahe R, Pääkkönen K, Hartikainen J, Blomqvist C, Löppönen T, Holli K, Ryynänen M, Bützow R, Borg A, Wasteson Arver B, Holmberg E, Mannermaa A, Kere J, Kallioniemi OP, Winqvist R, Nevanlinna H. Sarantaus L, et al. Among authors: mannermaa a. Eur J Hum Genet. 2000 Oct;8(10):757-63. doi: 10.1038/sj.ejhg.5200529. Eur J Hum Genet. 2000. PMID: 11039575

4

A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.

Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA. Healey CS, et al. Among authors: mannermaa a. Nat Genet. 2000 Nov;26(3):362-4. doi: 10.1038/81691. Nat Genet. 2000. PMID: 11062481

5

Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables.

Launonen V, Mannermaa A, Stenbäck F, Kosma VM, Puistola U, Huusko P, Anttila M, Bloigu R, Saarikoski S, Kauppila A, Winqvist R. Launonen V, et al. Among authors: mannermaa a. Cancer Genet Cytogenet. 2000 Oct 1;122(1):49-54. doi: 10.1016/s0165-4608(00)00279-x. Cancer Genet Cytogenet. 2000. PMID: 11104033

6

A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.

Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. Dunning AM, et al. Among authors: mannermaa a. Cancer Res. 2003 May 15;63(10):2610-5. Cancer Res. 2003. PMID: 12750287

7

Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.

Tuhkanen H, Anttila M, Kosma VM, Ylä-Herttuala S, Heinonen S, Kuronen A, Juhola M, Tammi R, Tammi M, Mannermaa A. Tuhkanen H, et al. Among authors: mannermaa a. Int J Cancer. 2004 Mar 20;109(2):247-52. doi: 10.1002/ijc.11733. Int J Cancer. 2004. PMID: 14750176

8

Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.

Tuhkanen H, Anttila M, Kosma VM, Puolakka J, Juhola M, Heinonen S, Mannermaa A. Tuhkanen H, et al. Among authors: mannermaa a. Gynecol Oncol. 2004 Aug;94(2):416-21. doi: 10.1016/j.ygyno.2004.04.029. Gynecol Oncol. 2004. PMID: 15297182

9

An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found.

Hartikainen JM, Tuhkanen H, Kataja V, Dunning AM, Antoniou A, Smith P, Arffman A, Pirskanen M, Easton DF, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. Hartikainen JM, et al. Among authors: mannermaa a. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):75-80. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668479

10

Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.

Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. Hartikainen JM, et al. Among authors: mannermaa a. Clin Cancer Res. 2006 Mar 1;12(5):1454-62. doi: 10.1158/1078-0432.CCR-05-1417. Clin Cancer Res. 2006. PMID: 16533768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters